Intervention
green tea extract
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 7 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
7 shownGreen Tea Extract on Soluble RAGE in Patients With Diabetic NephropathyNCT03622762 · 2018-07-15
UNKNOWNEffect of Green Tea Extract on Arterial Stiffness in Type 2 Diabetes MellitusNCT02627898 · 2016-01-01
COMPLETEDEffect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing SurgeryNCT01912820 · 2014-01-01
COMPLETEDEffects of Green Tea Extract on Obese Women With High Level of LDLNCT02116517 · 2011-08-01
COMPLETEDThe Effect of Green Tea or Cocoa Extracts in Endothelial Dysfunction in Patients With Diabetes MellitusNCT01130727 · 2010-05-01
COMPLETEDEffects of Green Tea Extract (GTE) on Systemic Oxidative and Antioxidative Status in Chinese Patients With Stable AsthmaNCT01187147 · 2008-01-01
COMPLETEDGreen Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyNCT00005828 · 2000-12-01
COMPLETEDCommon conditions
Adenocarcinoma of the Prostate1Arterial Hypertension1Asthma1Diabetes Mellitus1Diabetic Nephropathy1Diabetic Nephropathy Type 21Hyperlipidemia1Obese1Prostate Cancer1Recurrent Prostate Cancer1Stage I Prostate Cancer1Stage IIA Prostate Cancer1Stage IIB Prostate Cancer1Stage III Prostate Cancer1Stage IV Prostate Cancer1Type 2 Diabetes Mellitus1
Leading sponsors
Trial status mix
COMPLETED6
UNKNOWN1
Phase mix
PHASE23
NA2
PHASE11
PHASE31
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.